Pfizer Ltd.

Financial

	Pfizer	JB Chem & Pharma	Wockhardt
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	8.7 %	10.1 %	10.6 %
Financials
5 yr Average ROE	19.03 %	19.44 %	-3.81 %
5yr average Equity Multiplier	1.25	1.5	2.26
5yr Average Asset Turnover Ratio	0.6	0.79	0.39
5yr Avg Net Profit Margin	26.04 %	16.41 %	-4.46 %
Price to Book	6.28	7.45	6.45
P/E	34.48	39.17	0.0
5yr Avg Cash Conversion Cycle	21.86 Days	19.31 Days	-118.47 Days
Inventory Days	49.93 Days	51.72 Days	68.12 Days
Days Receivable	29.1 Days	63.93 Days	71.63 Days
Days Payable	77.28 Days	85.63 Days	260.3 Days
5yr Average Interest Coverage Ratio	185.18	65.09	-0.67
5yr Avg ROCE	23.84 %	23.24 %	-1.45 %
5yr Avg Operating Profit Margin	31.72 %	23.72 %	3.11 %
5 yr average Debt to Equity	0.0	0.08	0.71
5yr CAGR Net Profit	76.68 %	15.23 %	46.24 %
5yr Average Return on Assets	15.25 %	13.06 %	-1.84 %
Shareholdings
Promoter Holding	63.92 %	47.84 %	49.09 %
Share Pledged by Promoters	0.0	0.0	18.24 %
Change in Promoter Holding (3 Yrs)	0.0	-6.16 %	-18.04 %
Change in Mutual Fund Holding (3 Yrs)	3.65 %	1.99 %	7.53 %

Business

	Pfizer	JB Chem & Pharma	Wockhardt
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 0 Formulations 29.72 Pharmaceuticals 0 Contract Manufacturing 13.59 Domestic Formulations 54.69 Active Pharmaceutical Ingredient (API) 2.0	Product Wise Break-Up Pharmaceutical 0 Formulation exported 0 Pharmaceutical 100.0 CDMO 0 Domestic formulation 0 API 0
Location Wise Break-Up	Location Wise Break-Up India 96.14 Rest of the World 3.86 Russia 0 South Africa 0 USA 0 Europe 0	Location Wise Break-Up USA 0 South Africa 0 Russia 0 India 54.32 Europe 0 Rest of the World 45.68	Location Wise Break-Up USA 0 South Africa 0 Russia 0 India 21.89 Europe 0 Rest of the World 78.11